To investigate the impact of MSA-related neuropathological processes on astrocytes on a cellular level, we developed an astrocyte isolation method with high purity modified from an existing surface marker-based sorting protocol using ATP1B2 as an unbiased astrocyte-specific surface marker [61] and subsequent astrocyte RNA sequencing. The gene discussed is ATP1B2; the disease is multiple system atrophy.